3755
|
(+)-Abscisic acid
|
LANCL2 ligand |
€90.00
|
3433
|
ARB-272572
|
Potent, cellular active PD-L1 inhibitor |
€150.00
|
2624
|
BF844
|
CLRN1-N48K stabilizer |
€105.00
|
4247
|
BMS202 hydrochloride
|
PD-1/PD-L1 interaction inhibitor |
Recently added
|
€140.00
|
3017
|
BRD4780
|
Potent and selective imidazoline1 (I1) receptor ligand; TMED9 binder |
€95.00
|
2749
|
BT-11
|
First-in-class, orally active LANCL2 binding compound |
€110.00
|
3437
|
BTYNB
|
Potent and selective IMP1 inhibitor |
€90.00
|
3441
|
KL001
|
Cryptochrome stabilizer |
€120.00
|
3694
|
PD-1 Inhibitor 16
|
PD-1 inhibitor |
Inquire
|
2875
|
PD-1 inhibitor compound 9
|
Inhibitor of programmed death-1 (PD-1) protein |
Inquire
|
4083
|
PDS0330
|
Potent and selective first-generation claudin-1 inhibitor |
€140.00
|
4249
|
Salubrinal
|
Selective eIF2α dephosphorylation inhibitor |
€110.00
|
2700
|
TD52
|
CIP2A inhibitor; Erlotinib derivative |
€95.00
|